- This topic has 0 replies, 1 voice, and was last updated 1 month ago by
.
Viewing 0 reply threads
-
Posts
-
-
It’ll be a little longer before the Food and Drug Administration decides whether it will approve Ofatumumab. That decision is now hoped for by September. Ofatumumab would be the only a monoclonal antibody therapy available as a self-injection. The rest are infusions. Sound like something you’d ask your neuro about?
-
Viewing 0 reply threads
- You must be logged in to reply to this topic.
